NCT02618122View on ClinicalTrials.gov

A Multicenter, Prospective, oBservational Study to assEss the Clinical activitY and Impact on symptOm Burden and patieNts' HRQoL of Treatment With trabecteDin in aSTS in a Real World Setting in Greece

CompletedOBSERVATIONAL
Enrollment

63

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

June 30, 2019

Study Completion Date

August 6, 2019

Conditions
Advanced Soft Tissue Sarcoma
Trial Locations (1)

Unknown

Thessaloniki, Thessaloniki

Sponsors
All Listed Sponsors
lead

Genesis Pharma S.A.

INDUSTRY

NCT02618122 - A Multicenter, Prospective, oBservational Study to assEss the Clinical activitY and Impact on symptOm Burden and patieNts' HRQoL of Treatment With trabecteDin in aSTS in a Real World Setting in Greece | Biotech Hunter | Biotech Hunter